COVID-19 Impact on Global CAR T-Cell Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Allogeneic
  • 1.4.3 Autologous
• 1.5 Market by Application
  • 1.5.1 Global CAR T-Cell Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Cancer Research Centers
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Therapy Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the CAR T-Cell Therapy Industry
    • 1.6.1.1 CAR T-Cell Therapy Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and CAR T-Cell Therapy Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for CAR T-Cell Therapy Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 CAR T-Cell Therapy Market Perspective (2015-2026)
• 2.2 CAR T-Cell Therapy Growth Trends by Regions
  • 2.2.1 CAR T-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 CAR T-Cell Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 CAR T-Cell Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 CAR T-Cell Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key CAR T-Cell Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top CAR T-Cell Therapy Players by Market Size
  • 3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global CAR T-Cell Therapy Market Concentration Ratio
  • 3.2.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2019
• 3.3 CAR T-Cell Therapy Key Players Head office and Area Served
• 3.4 Key Players CAR T-Cell Therapy Product Solution and Service
• 3.5 Date of Enter into CAR T-Cell Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2021-2026)

5 CAR T-Cell Therapy Breakdown Data by Application (2015-2026)

• 5.1 Global CAR T-Cell Therapy Market Size by Application (2015-2020)
• 5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America CAR T-Cell Therapy Market Size (2015-2020)
• 6.2 CAR T-Cell Therapy Key Players in North America (2019-2020)
• 6.3 North America CAR T-Cell Therapy Market Size by Type (2015-2020)
• 6.4 North America CAR T-Cell Therapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe CAR T-Cell Therapy Market Size (2015-2020)
• 7.2 CAR T-Cell Therapy Key Players in Europe (2019-2020)
• 7.3 Europe CAR T-Cell Therapy Market Size by Type (2015-2020)
• 7.4 Europe CAR T-Cell Therapy Market Size by Application (2015-2020)

8 China

• 8.1 China CAR T-Cell Therapy Market Size (2015-2020)
• 8.2 CAR T-Cell Therapy Key Players in China (2019-2020)
• 8.3 China CAR T-Cell Therapy Market Size by Type (2015-2020)
• 8.4 China CAR T-Cell Therapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan CAR T-Cell Therapy Market Size (2015-2020)
• 9.2 CAR T-Cell Therapy Key Players in Japan (2019-2020)
• 9.3 Japan CAR T-Cell Therapy Market Size by Type (2015-2020)
• 9.4 Japan CAR T-Cell Therapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia CAR T-Cell Therapy Market Size (2015-2020)
• 10.2 CAR T-Cell Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia CAR T-Cell Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia CAR T-Cell Therapy Market Size by Application (2015-2020)

11 India

• 11.1 India CAR T-Cell Therapy Market Size (2015-2020)
• 11.2 CAR T-Cell Therapy Key Players in India (2019-2020)
• 11.3 India CAR T-Cell Therapy Market Size by Type (2015-2020)
• 11.4 India CAR T-Cell Therapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America CAR T-Cell Therapy Market Size (2015-2020)
• 12.2 CAR T-Cell Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America CAR T-Cell Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America CAR T-Cell Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Celgene (Juno Therapeutics)
  • 13.1.1 Celgene (Juno Therapeutics) Company Details
  • 13.1.2 Celgene (Juno Therapeutics) Business Overview and Its Total Revenue
  • 13.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction
  • 13.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2015-2020))
  • 13.1.5 Celgene (Juno Therapeutics) Recent Development
• 13.2 Novartis
  • 13.2.1 Novartis Company Details
  • 13.2.2 Novartis Business Overview and Its Total Revenue
  • 13.2.3 Novartis CAR T-Cell Therapy Introduction
  • 13.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.2.5 Novartis Recent Development
• 13.3 Gilead (Kite Pharma)
  • 13.3.1 Gilead (Kite Pharma) Company Details
  • 13.3.2 Gilead (Kite Pharma) Business Overview and Its Total Revenue
  • 13.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction
  • 13.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.3.5 Gilead (Kite Pharma) Recent Development
• 13.4 Pfizer
  • 13.4.1 Pfizer Company Details
  • 13.4.2 Pfizer Business Overview and Its Total Revenue
  • 13.4.3 Pfizer CAR T-Cell Therapy Introduction
  • 13.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.4.5 Pfizer Recent Development
• 13.5 CARsgen Therapeutics
  • 13.5.1 CARsgen Therapeutics Company Details
  • 13.5.2 CARsgen Therapeutics Business Overview and Its Total Revenue
  • 13.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
  • 13.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.5.5 CARsgen Therapeutics Recent Development
• 13.6 Autolus Therapeutics
  • 13.6.1 Autolus Therapeutics Company Details
  • 13.6.2 Autolus Therapeutics Business Overview and Its Total Revenue
  • 13.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
  • 13.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.6.5 Autolus Therapeutics Recent Development
• 13.7 Aurora BioPharma
  • 13.7.1 Aurora BioPharma Company Details
  • 13.7.2 Aurora BioPharma Business Overview and Its Total Revenue
  • 13.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction
  • 13.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.7.5 Aurora BioPharma Recent Development
• 13.8 Sorrento Therapeutics
  • 13.8.1 Sorrento Therapeutics Company Details
  • 13.8.2 Sorrento Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
  • 13.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.8.5 Sorrento Therapeutics Recent Development
• 13.9 Mustang Bio
  • 13.9.1 Mustang Bio Company Details
  • 13.9.2 Mustang Bio Business Overview and Its Total Revenue
  • 13.9.3 Mustang Bio CAR T-Cell Therapy Introduction
  • 13.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.9.5 Mustang Bio Recent Development
• 13.10 Bluebird Bio
  • 13.10.1 Bluebird Bio Company Details
  • 13.10.2 Bluebird Bio Business Overview and Its Total Revenue
  • 13.10.3 Bluebird Bio CAR T-Cell Therapy Introduction
  • 13.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 13.10.5 Bluebird Bio Recent Development
• 13.11 Collectis
  • 10.11.1 Collectis Company Details
  • 10.11.2 Collectis Business Overview and Its Total Revenue
  • 10.11.3 Collectis CAR T-Cell Therapy Introduction
  • 10.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 10.11.5 Collectis Recent Development
• 13.12 Allogene Therapeutics
  • 10.12.1 Allogene Therapeutics Company Details
  • 10.12.2 Allogene Therapeutics Business Overview and Its Total Revenue
  • 10.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
  • 10.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 10.12.5 Allogene Therapeutics Recent Development
• 13.13 Celyad
  • 10.13.1 Celyad Company Details
  • 10.13.2 Celyad Business Overview and Its Total Revenue
  • 10.13.3 Celyad CAR T-Cell Therapy Introduction
  • 10.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2015-2020)
  • 10.13.5 Celyad Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer